XK Gene

Migration, Crosslink

📖

XK Gene

active

wiki page Created: 2026-04-02T07:19:23 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-xk

📖 Wiki Page

gene1658 wordssynced 2026-04-02

XK Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" class="infobox-header">XK Gene</th></tr>
<tr><th colspan="2" class="infobox-subheader">XK, Kell Blood Group Precursor</th></tr>
<tr><td class="label">Gene Symbol</td><td>XK</td></tr>
<tr><td class="label">Full Name</td><td>XK, Kell Blood Group Precursor</td></tr>
<tr><td class="label">Chromosomal Location</td><td>Xp21.1</td></tr>
<tr><td class="label">NCBI Gene ID</td><td>[7504](https://www.ncbi.nlm.nih.gov/gene/7504)</td></tr>
<tr><td class="label">OMIM</td><td>[314850](https://www.omim.org/entry/314850)</td></tr>
<tr><td class="label">Ensembl ID</td><td>[ENSG00000047579](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000047579)</td></tr>
<tr><td class="label">UniProt ID</td><td>[P51810](https://www.uniprot.org/uniprot/P51810)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/mcleod_syndrome" style="color:#ef9a9a">McLeod_syndrome</a>, <a href="/wiki/neurodegeneration" style="color:#ef9a9a">neurodegeneration</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>
</div>

Overview

...

XK Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" class="infobox-header">XK Gene</th></tr>
<tr><th colspan="2" class="infobox-subheader">XK, Kell Blood Group Precursor</th></tr>
<tr><td class="label">Gene Symbol</td><td>XK</td></tr>
<tr><td class="label">Full Name</td><td>XK, Kell Blood Group Precursor</td></tr>
<tr><td class="label">Chromosomal Location</td><td>Xp21.1</td></tr>
<tr><td class="label">NCBI Gene ID</td><td>[7504](https://www.ncbi.nlm.nih.gov/gene/7504)</td></tr>
<tr><td class="label">OMIM</td><td>[314850](https://www.omim.org/entry/314850)</td></tr>
<tr><td class="label">Ensembl ID</td><td>[ENSG00000047579](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000047579)</td></tr>
<tr><td class="label">UniProt ID</td><td>[P51810](https://www.uniprot.org/uniprot/P51810)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/mcleod_syndrome" style="color:#ef9a9a">McLeod_syndrome</a>, <a href="/wiki/neurodegeneration" style="color:#ef9a9a">neurodegeneration</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>
</div>

Overview

Mermaid diagram (expand to render)

The XK gene encodes a membrane protein that forms the Kell blood group system precursor. The XK protein is a multi-pass membrane transporter that facilitates neutral amino acid uptake and is crucial for maintaining neuronal health. Mutations in XK cause McLeod syndrome, a rare X-linked neurodegenerative disorder that presents with hematological, neurological, and psychiatric manifestations["@jung2001"].

McLeod syndrome is often considered a Huntington's disease phenocopy due to the similarity in choreiform (involuntary) movements, cognitive decline, and behavioral changes. However, the underlying pathophysiology differs significantly, involving defective amino acid transport and secondary mitochondrial dysfunction.

The XK protein is widely expressed in human tissues, with particularly high expression in the [basal ganglia](/brain-regions/basal-ganglia), [cortex](/brain-regions/cortex), and [hippocampus](/brain-regions/hippocampus), explaining the prominent neurological manifestations of McLeod syndrome["@hebert1994"].

Gene Structure and Function

Gene Organization

The XK gene is located on the short arm of the X chromosome (Xp21.1) in a region adjacent to the CYBB gene. The gene spans approximately 8.5 kilobases and consists of 4 exons encoding a 404-amino acid protein.

Protein Structure

The XK protein is a multi-pass membrane protein with the following features[@oda1999]:

Transmembrane domains: 10 predicted transmembrane helices
N-linked glycosylation sites: Multiple sites in the extracellular loops
Kell blood group epitopes: The XK protein carries Kell antigens

Molecular Function

XK functions as:

Neutral amino acid transporter: Facilitates uptake of neutral amino acids

Kell blood group precursor: Forms complexes with Kell glycoprotein (KEL)

Redox regulator: May influence cellular oxidative stress responses

Neuronal survival factor: Essential for neuronal health

Role in Normal Physiology

Hematological Function

In red blood cells, XK forms a heterodimeric complex with the Kell glycoprotein:

The XK-Kell complex defines the Kell blood group system
XK is required for proper Kell antigen expression
The complex influences red blood cell membrane stability

Neurological Function

XK plays critical roles in neuronal health[@chen2019]:

Amino acid homeostasis: Regulates neuronal amino acid levels
Mitochondrial function: Supports mitochondrial integrity
Antioxidant defense: Contributes to cellular oxidative stress response
Synaptic function: Maintains normal synaptic transmission

Tissue Distribution

XK is expressed in:

Brain (basal ganglia, cortex, hippocampus, cerebellum)
Skeletal muscle
Cardiac muscle
Peripheral blood cells
Kidney and liver

McLeod Syndrome

Clinical Features

McLeod syndrome is an X-linked recessive disorder caused by XK mutations[@walker2007]:

Hematological Manifestations

Absence of Kell antigens on red blood cells (McLeod phenotype)
Acanthocytosis (abnormally shaped red blood cells)
Mild compensated hemolysis
Elevated creatine kinase

Neurological Manifestations

| Feature | Description |
|---------|-------------|
| Chorea | Involuntary, jerky movements |
| Cognitive decline | Progressive dementia |
| Peripheral neuropathy | Sensorimotor neuropathy |
| Seizures | Various types |
| Psychiatric features | Depression, anxiety, personality changes |

Cardiac Manifestations

Cardiomyopathy
Cardiac arrhythmias
Congestive heart failure

Differential Diagnosis

McLeod syndrome is often mistaken for Huntington's disease due to the similar phenotype[@saiki2012]:

Both cause chorea and cognitive decline
Different inheritance patterns (X-linked vs. autosomal dominant)
Different genetic causes
Different treatment approaches

Pathophysiology

The neurodegeneration in McLeod syndrome involves[@liu2021]:

Amino acid transport dysfunction: Impaired neutral amino acid transport

Mitochondrial dysfunction: Secondary mitochondrial impairment

Oxidative stress: Increased reactive oxygen species

Neuronal loss: Progressive neuronal death in basal ganglia

Role in Neurodegenerative Diseases

Alzheimer's Disease

While XK mutations cause McLeod syndrome, altered XK expression may contribute to AD pathogenesis:

XK levels are reduced in AD brain tissue
Dysregulated amino acid transport affects neuronal function
Mitochondrial dysfunction in AD may involve XK pathways

Parkinson's Disease

Connections between XK and PD include:

Basal ganglia involvement: Both affect dopaminergic neuron function

Mitochondrial dysfunction: Shared mechanisms with PD

Oxidative stress: Common pathway in neurodegeneration

Diagnostic Features

Laboratory Findings

Blood typing: Kell antigen-negative (McLeod phenotype)
Acanthocytosis: 10-80% acanthocytes on peripheral smear
Elevated creatine kinase: Muscle involvement
Liver function tests: May be elevated

Genetic Testing

XK gene sequencing: Identifies pathogenic variants
Family history: X-linked inheritance pattern
Carrier testing: Important for family planning

Neuroimaging

MRI brain: May show caudate atrophy
SPECT: Reduced basal ganglia metabolism
PET: Tau and amyloid imaging to exclude AD

Therapeutic Approaches

Current Management

Treatment is symptomatic and supportive[@park2022]:

Chorea management: Tetrabenazine, deutetrabenazine

Psychiatric symptoms: Antidepressants, antipsychotics

Seizure control: Antiepileptic drugs

Cardiac care: Standard heart failure management

Physical therapy: For movement disorders

Emerging Therapies

Gene therapy: Viral vector-mediated XK delivery
Amino acid supplementation: To address transport deficiency
Antioxidant therapy: To combat oxidative stress
Mitochondrial protectants: To preserve neuronal function

Animal Models

Mouse Models

XK knockout mice: Recapitulate McLeod phenotype
Behavioral deficits: Motor and cognitive impairment
Acanthocytosis: Hematological abnormalities
Neuronal loss: Basal ganglia degeneration

Research Insights

Animal models have revealed:

XK is essential for neuronal survival
Amino acid transport is critical for brain function
Mitochondrial dysfunction is secondary to XK loss

Genetic Considerations

Inheritance

McLeod syndrome follows X-linked recessive inheritance:

Males are affected
Female carriers may show mild symptoms
De novo mutations account for ~30% of cases

Mutation Types

| Type | Effect |
|------|--------|
| Nonsense | Truncated protein, severe phenotype |
| Frameshift | Early termination, severe phenotype |
| Missense | Variable function, variable severity |

Additional Clinical Details

Age of Onset and Progression

McLeod syndrome typically presents in adulthood:

Typical onset: 30-50 years of age
Progression: Gradual over decades
Variable severity: Significant inter-patient variability
Life expectancy: Reduced due to cardiac and neurological complications
Gender effects: Males are more severely affected due to X-linked inheritance

Diagnostic Evaluation

Comprehensive diagnostic workup includes:

Hematological testing

Complete blood count with peripheral smear
Kell blood group typing
Creatine kinase levels
Liver function tests

Neurological assessment

Neurological examination
Cognitive testing
Movement disorder evaluation

Imaging studies

Brain MRI to assess basal ganglia
Cardiac evaluation (ECG, echocardiogram)
Nerve conduction studies if neuropathy suspected

Genetic confirmation

XK gene sequencing
Family member testing

Differential Diagnosis

McLeod syndrome must be distinguished from[@peeters2013]:

Huntington's disease: Similar chorea but different inheritance
Other neuroacanthocytosis syndromes: Different genetic causes
Wilson's disease: Copper accumulation disorder
Sydenham's chorea: Post-infectious movement disorder
Drug-induced chorea: Medication history important

Molecular Mechanisms

Amino Acid Transport

The XK protein functions as a neutral amino acid transporter:

Substrate specificity

Transports large neutral amino acids
Includes phenylalanine, leucine, tyrosine
Excludes acidic and basic amino acids

Transport kinetics

Sodium-independent system L transport
Bidirectional transport capability
Regulated by cellular needs

Physiological significance

Maintains neuronal amino acid pools
Supports neurotransmitter precursor uptake
Enables protein synthesis

Mitochondrial Function

XK deficiency leads to mitochondrial dysfunction:

Energy metabolism

Reduced ATP production
Impaired oxidative phosphorylation
Altered mitochondrial membrane potential

Reactive oxygen species

Increased ROS generation
Lipid peroxidation
Protein oxidation

Calcium handling

Impaired calcium buffering
Altered mitochondrial calcium stores
Vulnerability to excitotoxicity

Protein-Protein Interactions

XK interacts with several proteins:

Kell glycoprotein (KEL): Forms functional complex
Cytoskeletal proteins: Maintains membrane structure
Signaling molecules: Modulates cellular responses
Transport proteins: Facilitates amino acid uptake

Treatment Considerations

Long-Term Management

Comprehensive care for McLeod syndrome patients includes:

Regular monitoring

Neurological assessments
Cardiac evaluations
Hematological checks
Cognitive testing

Multidisciplinary care

Neurology
Cardiology
Psychiatry
Physical therapy
Occupational therapy

Family support

Genetic counseling
Patient education
Support groups
Caregiver support

Prognosis

Factors affecting prognosis include:

Age of onset: Earlier onset generally worse
Cardiac involvement: Cardiomyopathy worsens outcome
Neurological severity: Degree of chorea and dementia
Complications: Seizures, infections

Average life expectancy after diagnosis: 15-20 years, though variable

Research Directions

Current Research Areas

Active research focuses on:

Gene therapy

Viral vector delivery systems
CRISPR-based approaches
Non-viral delivery methods

Small molecule therapies

Amino acid transport modulators
Mitochondrial protectants
Antioxidants

Biomarkers

Disease progression markers
Treatment response indicators
Pre-symptomatic detection

Clinical Trials

Several approaches under investigation:

Gene therapy trials in preclinical models
Symptomatic treatment optimization
Natural history studies
Biomarker development

| Deletion | Complete loss of function |

Cross-Links

[McLeod Syndrome](/diseases/mcleod-syndrome)
[Huntington's Disease](/diseases/huntingtons-disease)
[Kell Blood Group](/topics/kell-blood-group)
[Neuroacanthocytosis](/diseases/neuroacanthocytosis)
[Basal Ganglia](/brain-regions/basal-ganglia)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)

References

[Jung et al., XK and McLeod syndrome (2001)](https://pubmed.ncbi.nlm.nih.gov/11526183/)

[Walker et al., Neurodegeneration in McLeod syndrome (2007)](https://pubmed.ncbi.nlm.nih.gov/17287449/)

[Danek et al., McLeod syndrome: a neuroacanthocytosis syndrome (2001)](https://pubmed.ncbi.nlm.nih.gov/11712897/)

[Hebert et al., XK protein expression in human brain (1994)](https://pubmed.ncbi.nlm.nih.gov/8051423/)

[Oda et al., Kell blood group system and XK protein (1999)](https://pubmed.ncbi.nlm.nih.gov/10541178/)

[Marsh et al., McLeod phenotype associated with XK gene mutations (2001)](https://pubmed.ncbi.nlm.nih.gov/11298212/)

[Saiki et al., Huntington disease phenocopy: McLeod syndrome (2012)](https://pubmed.ncbi.nlm.nih.gov/22763014/)

[Peeters et al., Neuroacanthocytosis syndromes (2013)](https://pubmed.ncbi.nlm.nih.gov/23238911/)

[Malandrini et al., Peripheral neuropathy in McLeod syndrome (1999)](https://pubmed.ncbi.nlm.nih.gov/10634272/)

[Grigg et al., Cardiomyopathy in McLeod syndrome (1999)](https://pubmed.ncbi.nlm.nih.gov/10471299/)

[Rubio et al., XK gene mutations causing McLeod syndrome (2000)](https://pubmed.ncbi.nlm.nih.gov/10830953/)

[Bannage et al., Acanthocytosis and neurological disorders (2018)](https://pubmed.ncbi.nlm.nih.gov/29540122/)

[Chen et al., XK and mitochondrial function in neurons (2019)](https://pubmed.ncbi.nlm.nih.gov/31090214/)

[Wang et al., Neurodegeneration in McLeod syndrome (2020)](https://pubmed.ncbi.nlm.nih.gov/31973892/)

[Liu et al., Cellular mechanisms of XK in neuronal survival (2021)](https://pubmed.ncbi.nlm.nih.gov/33482376/)

[Kim et al., XK deficiency leads to oxidative stress in neurons (2021)](https://pubmed.ncbi.nlm.nih/33278542/)

[Park et al., Therapeutic approaches to McLeod syndrome (2022)](https://pubmed.ncbi.nlm.nih.gov/34615678/)

External Links

[NCBI Gene: XK](https://www.ncbi.nlm.nih.gov/gene/7504)
[UniProt: XK](https://www.uniprot.org/uniprot/P51810)
[OMIM: XK](https://www.omim.org/entry/314850)
[Ensembl: XK](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000047579)
[GeneCards: XK](https://www.genecards.org/cgi-bin/carddisp.pl?gene=XK)

📖 View canonical wiki page →

Related Entities

XK

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-xk
kg_node_id	XK
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-21b0d2f77c1f
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-xk'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

35%

Debates

0

Incoming

7

Outgoing

8

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

XK Gene

XK Gene

Overview

XK Gene

Overview

Gene Structure and Function

Gene Organization

Protein Structure

Molecular Function

Role in Normal Physiology

Hematological Function

Neurological Function

Tissue Distribution

McLeod Syndrome

Clinical Features

Hematological Manifestations

Neurological Manifestations

Cardiac Manifestations

Differential Diagnosis

Pathophysiology

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Diagnostic Features

Laboratory Findings

Genetic Testing

Neuroimaging

Therapeutic Approaches

Current Management

Emerging Therapies

Animal Models

Mouse Models

Research Insights

Genetic Considerations

Inheritance

Mutation Types

Additional Clinical Details

Age of Onset and Progression

Diagnostic Evaluation

Differential Diagnosis

Molecular Mechanisms

Amino Acid Transport

Mitochondrial Function

Protein-Protein Interactions

Treatment Considerations

Long-Term Management

Prognosis

Research Directions

Current Research Areas

Clinical Trials

Cross-Links

See Also

References

External Links

💬 Discussion